David Braga Malta is a life sciences entrepreneur, inventor and investor. David is currently managing the health PE fund of Group Pictet and previously he was a Venture Partner of Vesalius Biocapital III. As an entrepreneur David founded LiMM Therapeutics, Cell2B and BoostPharma, where he serves(ed) as manager. At LIMM David was founding CEO raising more than EUR 35M and recruiting a top team to move the company to clinical Development. David has been instrumental in supporting and growing Portugal’s life sciences sector, serving as a Board Member at P-BIO – Portugal’s Biotechnology Industry Organization, and acting as Venture Consultant for Caixa Capital where he helped to establish a Life Sciences investment policy for Portugal. He is a member of the World Economic Forum’s ‘Global Shapers’ community and has served as the curator of the Lisbon Hub.
His academic career focused on the use of stem cells in regenerative medicine, with several publications and patents in the field. David holds a PhD in Bioengineering from the MIT Portugal Program and an MSc in Biological Engineering from the Instituto Superior Técnico, Portugal.